IBDEI0GW ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8204,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,8204,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,8205,0)
 ;;=362.01^^58^607^32
 ;;^UTILITY(U,$J,358.3,8205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8205,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,8205,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,8206,0)
 ;;=362.02^^58^607^72
 ;;^UTILITY(U,$J,358.3,8206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8206,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,8206,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,8207,0)
 ;;=362.03^^58^607^64
 ;;^UTILITY(U,$J,358.3,8207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8207,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,8207,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,8208,0)
 ;;=362.04^^58^607^61
 ;;^UTILITY(U,$J,358.3,8208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8208,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,8208,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,8209,0)
 ;;=362.05^^58^607^62
 ;;^UTILITY(U,$J,358.3,8209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8209,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,8209,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,8210,0)
 ;;=362.06^^58^607^98
 ;;^UTILITY(U,$J,358.3,8210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8210,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,8210,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,8211,0)
 ;;=379.27^^58^607^103
 ;;^UTILITY(U,$J,358.3,8211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8211,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,8211,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,8212,0)
 ;;=115.02^^58^607^44
 ;;^UTILITY(U,$J,358.3,8212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8212,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=190.5^^58^607^58
 ;;^UTILITY(U,$J,358.3,8213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8213,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,8213,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,8214,0)
 ;;=198.4^^58^607^59
 ;;^UTILITY(U,$J,358.3,8214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8214,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,8214,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,8215,0)
 ;;=200.00^^58^607^81
 ;;^UTILITY(U,$J,358.3,8215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8215,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,8215,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,8215,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,8216,0)
 ;;=228.03^^58^607^38
 ;;^UTILITY(U,$J,358.3,8216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8216,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,8216,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,8216,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,8217,0)
 ;;=228.09^^58^607^39
 ;;^UTILITY(U,$J,358.3,8217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8217,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,8217,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,8217,2)
 ;;=^55270
